Savara

$0.00 (0.00%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.

About SVRA

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The firm's lead program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of autoimmune pulmonary alveolar proteinosis.

CEO

Matthew Pauls

Employees

Headquarters

Austin, Texas

Founded

1995

SVRA Key Statistics

Market Cap

206.83M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

281.99K

High Today

$1.34

Low Today

$1.28

Open Price

$1.28

Volume

207.43K

52 Week High

$3.58

52 Week Low

$0.9952

Analyst Ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

SVRA Earnings

-$0.41

-$0.27

-$0.14

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 12, After Hours